https://lifesciencesbc.ca/members/tecvayli-plus-darzalex-faspro-combination-regimen-significantly-improves-progression-free-survival-and-overall-survival-versus-standard-of-care/ 2025-10-16T16:58:38+00:00 https://lifesciencesbc.ca/members/me-therapeutics-granted-licence-for-cd22-nanobody-asset-to-expand-next-gen-in-vivo-car-cell-therapy-program/ 2025-10-16T17:11:13+00:00 https://lifesciencesbc.ca/members/bridging-innovation-and-care-phc-ventures-wins-big/ 2025-10-16T17:17:20+00:00 https://lifesciencesbc.ca/lsbc-news/life-sciences-bc-unveils-companies-and-mentors-for-sixth-annual-investor-readiness-program/ 2025-10-16T20:26:15+00:00 https://lifesciencesbc.ca/members/abbvie-completes-acquisition-of-gilgamesh-pharmaceuticals-bretisilocin/ 2025-10-17T18:49:27+00:00 https://lifesciencesbc.ca/members/newest-recognition-reinforces-biotalent-canadas-role-as-a-national-leader-in-workplace-excellence/ 2025-10-17T19:49:43+00:00 https://lifesciencesbc.ca/members/seed2stem-honoured-with-city-of-vancouver-leadership-in-reconciliation-award/ 2025-10-17T20:10:47+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-appoints-mr-john-bathery-to-its-board-of-directors/ 2025-10-17T20:17:30+00:00 https://lifesciencesbc.ca/members/molecular-you-earns-spot-on-fast-companys-2025-next-big-things-in-tech-list/ 2025-10-17T20:27:36+00:00 https://lifesciencesbc.ca/members/fuse-vectors-establishes-rd-for-gene-therapy-development-in-the-netherlands/ 2025-10-17T20:40:31+00:00 https://lifesciencesbc.ca/members/rapid-recap-ltc-staff-up-labour-mobility-moves/ 2025-10-17T23:02:08+00:00 https://lifesciencesbc.ca/members/vertex-announces-progress-in-povetacicept-development-program-and-presentation-of-new-data-at-american-society-of-nephrology-kidney-week/ 2025-10-17T23:10:48+00:00 https://lifesciencesbc.ca/members/rinvoq-upadacitinib-demonstrated-superiority-versus-humira-adalimumab-for-primary-endpoint-in-a-head-to-head-study-in-rheumatoid-arthritis-patients-who-have-failed-first-tnf-inhibitor/ 2025-10-20T20:33:52+00:00 https://lifesciencesbc.ca/members/beone-medicines-presents-new-data-on-tevimbra-in-lung-cancer-at-esmo-2025/ 2025-10-20T20:53:41+00:00 https://lifesciencesbc.ca/members/castl-responds-to-biomanufacturing-industry-demand-with-additional-pei-reskilling-cohorts/ 2025-10-20T21:07:45+00:00 https://lifesciencesbc.ca/members/johnson-johnsons-inlexzo-gemcitabine-intravesical-system-plus-cetrelimab-delivers-strong-pre-surgical-results-in-patients-with-muscle-invasive-bladder-cancer-scheduled-for-radica/ 2025-10-20T22:35:26+00:00 https://lifesciencesbc.ca/members/ai-driven-disease-detection-levels-up-prostate-cancer-surgery/ 2025-10-20T22:53:33+00:00 https://lifesciencesbc.ca/members/evonik-launches-eudracap-colon-functional-capsules-in-gmp-quality-at-cphi-frankfurt/ 2025-10-21T17:43:07+00:00 https://lifesciencesbc.ca/members/gsks-300000-investment-fuels-launch-of-innovative-lung-wellness-clinic-to-transform-respiratory-care-in-nova-scotia/ 2025-10-21T19:55:29+00:00 https://lifesciencesbc.ca/members/pfizer-canada-announces-health-canada-approval-of-abrysvo-for-adults-18/ 2025-10-21T22:22:21+00:00 https://lifesciencesbc.ca/members/bd-simplifies-at-home-hpv-testing-to-broaden-access-to-cervical-cancer-screening-outside-united-states/ 2025-10-22T21:22:48+00:00 https://lifesciencesbc.ca/members/dupixent-dupilumab-injection-approved-in-canada-for-adults-with-inadequately-controlled-chronic-obstructive-pulmonary-disease-copd/ 2025-10-22T21:50:07+00:00 https://lifesciencesbc.ca/members/certified-biobased-resins-bring-sustainable-lab-filtration-to-cytivas-customers/ 2025-10-23T18:58:31+00:00 https://lifesciencesbc.ca/members/bd-blog-press-releases-executive-leadership-in-the-news-awards-media-contacts-bd-launches-new-ai-enabled-solutions-to-drive-connectivity-across-healthcare-settings/ 2025-10-23T20:04:11+00:00 https://lifesciencesbc.ca/members/pfizer-canada-abrysvo-receives-expanded-public-funding-across-canadian-provinces-for-2025-2026-rsv-season/ 2025-10-24T21:01:01+00:00 https://lifesciencesbc.ca/members/new-study-highlights-concerning-link-between-heart-disease-and-shingles-risk/ 2025-10-24T21:39:15+00:00 https://lifesciencesbc.ca/members/icotrokinra-long-term-results-affirm-promise-of-targeted-oral-peptide-with-high-rates-of-durable-skin-clearance-and-favorable-safety-profile-in-difficult-to-treat-scalp-and-genital-psoriasis/ 2025-10-24T21:47:14+00:00 https://lifesciencesbc.ca/members/labcorp-to-offer-first-fda-cleared-blood-test-to-rule-out-alzheimers-related-amyloid-pathology-in-primary-care-settings/ 2025-10-24T21:56:17+00:00 https://lifesciencesbc.ca/members/sonus-microsystems-and-providence-health-care-ventures-advance-partnership-with-new-investment-to-accelerate-clinical-validation-of-wearable-cardiac-ultrasound-technology/ 2025-10-24T22:30:57+00:00 https://lifesciencesbc.ca/members/vertex-presents-new-data-across-portfolio-of-cystic-fibrosis-medicines-including-alyftrek-at-the-north-american-cystic-fibrosis-conference/ 2025-10-24T22:41:39+00:00 https://lifesciencesbc.ca/members/zymeworks-presents-initial-clinical-data-from-the-phase-1-trial-of-zw191-an-antibody-drug-conjugate-targeting-folate-receptor-%e2%8d%ba-at-aacr-nci-eortc-conference/ 2025-10-24T22:47:38+00:00 https://lifesciencesbc.ca/members/health-canada-grants-authorization-for-leqembi-lecanemab-for-the-treatment-of-early-alzheimers-disease/ 2025-10-27T16:27:41+00:00 https://lifesciencesbc.ca/members/new-study-reveals-substantial-unmet-need-in-psoriasis-shows-strong-patient-and-provider-preference-for-highly-effective-oral-treatments-with-favorable-safety-profile/ 2025-10-27T16:39:35+00:00 https://lifesciencesbc.ca/members/mentorship-and-care-shaping-the-vchri-research-challenge/ 2025-10-27T16:59:03+00:00 https://lifesciencesbc.ca/members/rheumnows-acr-2025-coverage-highlights-augurexs-data-on-anti-14-3-3eta-multiplex-immunoassay-test/ 2025-10-29T03:47:56+00:00 https://lifesciencesbc.ca/members/allergan-aesthetics-and-girls-inc-in-partnership-with-skinspirit-inspire-future-women-leaders-in-stem/ 2025-10-29T03:54:51+00:00 https://lifesciencesbc.ca/members/augurex-life-sciences-granted-fda-breakthrough-designation-for-spinestat-its-first-in-class-diagnostic-test-for-axial-spondyloarthritis/ 2025-10-29T04:06:33+00:00 https://lifesciencesbc.ca/members/rakovina-therapeutics-showcases-potent-ai-developed-atr-inhibitors-with-cns-penetrance-at-aacr-nci-eortc-international-conference/ 2025-10-29T04:38:15+00:00 https://lifesciencesbc.ca/members/14-5-million-will-move-research-in-sarcomas-bladder-cancer-and-high-risk-brain-cancer-beyond-one-size-fits-all-cancer-care/ 2025-10-29T04:45:17+00:00 https://lifesciencesbc.ca/members/dna-guided-platform-paves-way-for-more-precise-cancer-treatments/ 2025-10-29T04:54:03+00:00 https://lifesciencesbc.ca/members/enhertu-approved-in-canada-as-the-first-and-only-her2-directed-therapy-for-patients-with-hr-positive-her2-low-or-her2-ultralow-metastatic-breast-cancer-following-disease-progression-after-one-o/ 2025-10-29T15:38:40+00:00 https://lifesciencesbc.ca/members/abbvie-announces-positive-topline-results-from-phase-3-pivotal-studies-evaluating-upadacitinib-rinvoq-in-adults-and-adolescents-with-vitiligo/ 2025-10-29T16:43:37+00:00 https://lifesciencesbc.ca/members/glyconet-and-the-center-for-cooperative-research-in-biosciences-cic-biogune-enter-agreement-to-advance-global-glycomics-collaboration/ 2025-10-29T17:03:41+00:00 https://lifesciencesbc.ca/members/johnson-johnson-announces-first-head-to-head-study-comparing-imaavy-with-an-alternative-fcrn-blocker-in-generalized-myasthenia-gravis-gmg-at-aanem-annual-meeting/ 2025-10-29T17:14:14+00:00 https://lifesciencesbc.ca/members/elahere-receives-positive-reimbursement-recommendation-by-canadas-drug-agency-for-certain-types-of-platinum-resistant-ovarian-cancers/ 2025-10-30T16:55:10+00:00 https://lifesciencesbc.ca/ecosystem/dr-julia-levy-inducted-into-the-business-laureates-of-british-columbia-blbc-hall-of-fame/ 2025-10-31T00:08:31+00:00 https://lifesciencesbc.ca/wp-content/uploads/2025/10/Dr.-Julia-Levy.png https://lifesciencesbc.ca/members/providence-health-care-ventures-and-ventripoint-partner-to-validate-ai-enabled-cardiac-imaging-at-st-pauls-hospital/ 2025-11-03T19:30:32+00:00 https://lifesciencesbc.ca/members/dupixent-approved-in-canada-as-targeted-therapy-for-chronic-spontaneous-urticaria-csu/ 2025-11-03T19:43:11+00:00 https://lifesciencesbc.ca/members/united-therapeutics-corporation-announces-first-transplant-in-expand-clinical-trial-of-ukidney-in-patients-with-end-stage-renal-disease/ 2025-11-03T19:55:21+00:00 https://lifesciencesbc.ca/members/bd-achieves-milestone-in-agility-study-of-revello-vascular-covered-stent-for-treatment-of-peripheral-artery-disease/ 2025-11-04T21:51:47+00:00 https://lifesciencesbc.ca/members/bd-receives-fda-510k-clearance-and-ce-ivdr-certification-for-high-throughput-enteric-bacterial-panels-on-bd-cor-system/ 2025-11-04T23:12:54+00:00 https://lifesciencesbc.ca/members/vabysmo-faricimab-injection-pre-filled-syringe-now-publicly-funded-through-ontario-drug-benefit-odb-program/ 2025-11-04T23:40:45+00:00 https://lifesciencesbc.ca/members/emeterm-wristband-significantly-reduction-in-postoperative-nausea-and-vomiting-in-major-orthopedic-surgeries/ 2025-11-05T00:24:28+00:00 https://lifesciencesbc.ca/members/ubc-medicine-innovators-join-venture-founder-to-accelerate-global-health-solutions/ 2025-11-05T00:26:20+00:00 https://lifesciencesbc.ca/members/well-subsidiary-wellstar-technologies-announces-62m-financing-to-support-its-pre-spinout-growth-strategy/ 2025-11-05T00:37:06+00:00 https://lifesciencesbc.ca/members/gsk-survey-highlights-gaps-in-rsv-awareness-risk-understanding-among-vulnerable-older-canadian-adults/ 2025-11-05T18:32:55+00:00 https://lifesciencesbc.ca/members/idorsia-to-present-new-aprocitentan-insights-at-asn-kidney-week-aha-scientific-sessions/ 2025-11-05T19:26:40+00:00 https://lifesciencesbc.ca/members/quebec-expands-public-funding-for-capvaxive/ 2025-11-05T19:39:12+00:00 https://lifesciencesbc.ca/members/federal-budget-delivers-breakthrough-wins-for-canadas-life-sciences-sector/ 2025-11-06T00:49:32+00:00 https://lifesciencesbc.ca/members/johnson-johnson-submits-application-to-u-s-fda-for-stelara-ustekinumab-in-the-treatment-of-pediatric-ulcerative-colitis/ 2025-11-06T07:18:19+00:00 https://lifesciencesbc.ca/members/cytiva-unveils-fibro-dt-platform-for-enhanced-mrna-purification/ 2025-11-07T21:19:01+00:00 https://lifesciencesbc.ca/members/eyam-health-advances-cell-programming-platform-for-infectious-diseases-with-global-health-funded-large-animal-studies/ 2025-11-07T21:29:47+00:00 https://lifesciencesbc.ca/members/darzalex-faspro-is-the-first-and-only-treatment-approved-by-the-u-s-fda-for-patients-with-high-risk-smoldering-multiple-myeloma/ 2025-11-07T23:27:04+00:00 https://lifesciencesbc.ca/members/rezurock-now-covered-in-quebec-for-people-living-with-chronic-graft-versus-host-disease-gvhd/ 2025-11-07T23:40:10+00:00 https://lifesciencesbc.ca/members/idorsias-aprocitentan-improved-key-prognostic-indicators-in-patients-with-difficult-to-control-hypertension/ 2025-11-10T21:28:01+00:00 https://lifesciencesbc.ca/members/eight-out-of-10-infants-and-newborns-in-canada-have-access-to-rsv-prevention-with-beyfortus-this-season/ 2025-11-10T21:49:22+00:00 https://lifesciencesbc.ca/members/vertex-presents-updated-phase-1-2-data-from-ruby-3-study-that-continue-to-demonstrate-best-in-class-potential-for-povetacicept-in-adults-with-iga-nephropathy-and-primary-membranous-nephropathy-at-amer/ 2025-11-11T00:13:06+00:00 https://lifesciencesbc.ca/members/jade-biosciences-presents-new-data-demonstrating-a-favorable-preclinical-safety-profile-of-jade101-and-a-translational-analysis-of-april-mediated-biomarker-responses-at-the-american-society-of-nephrol/ 2025-11-11T00:14:06+00:00 https://lifesciencesbc.ca/members/hologic-introduces-digital-pathology-capabilities-with-expanded-ce-marking/ 2025-11-12T19:54:55+00:00 https://lifesciencesbc.ca/members/bd-expands-purewick-portfolio-with-first-of-its-kind-portable-solution-to-confidently-manage-urinary-incontinence-on-the-go/ 2025-11-13T17:47:26+00:00 https://lifesciencesbc.ca/members/rapid-recap-pcpas-enp-tnp-pathways/ 2025-11-13T20:56:14+00:00 https://lifesciencesbc.ca/members/duncan-regional-hospital-becomes-first-in-u-s-to-implement-bd-alaris-emr-infusion-interoperability-with-meditech/ 2025-11-14T17:41:53+00:00 https://lifesciencesbc.ca/members/eupraxia-pharmaceuticals-reports-additional-52-week-follow-up-data-from-the-resolve-trial-in-eosinophilic-esophagitis-eoe-demonstrating-consistent-results-after-dosing-with-ep-104gi/ 2025-11-14T17:56:41+00:00 https://lifesciencesbc.ca/members/cerecura-secures-1-4-million-to-tackle-brain-disorders-with-covid-era-vaccine-tech/ 2025-11-14T22:11:50+00:00 https://lifesciencesbc.ca/members/waving-goodbye-to-contamination-testing-nztechs-touchless-technology-in-the-or/ 2025-11-14T22:37:27+00:00 https://lifesciencesbc.ca/members/augurex-life-sciences-corp-announces-the-launch-of-the-14-3-3eta-test-for-rheumatoid-arthritis-diagnosis-and-monitoring-with-sonic-reference-laboratory/ 2025-11-17T19:48:16+00:00 https://lifesciencesbc.ca/members/lupron-depot-new-strength-receives-health-canada-approval-for-the-treatment-of-advanced-prostate-cancer/ 2025-11-17T21:43:19+00:00 https://lifesciencesbc.ca/members/3d-bioprinting-neutral-tissues-using-a-fibrin-bioink-containing-drug-releasing-microspheres/ 2025-11-17T21:56:21+00:00 https://lifesciencesbc.ca/members/zymeworks-announces-positive-herizon-gea-01-phase-3-results-supporting-ziihera-zanidatamab-hrii-as-her2-targeted-agent-of-choice-and-new-standard-of-care-in-first-line-her2-positive-locally/ 2025-11-17T23:56:26+00:00 https://lifesciencesbc.ca/members/new-long-term-data-reinforces-tremfya-guselkumab-as-the-only-il-23-inhibitor-proven-to-substantially-inhibit-structural-joint-damage-in-active-psoriatic-arthritis/ 2025-11-18T00:16:25+00:00 https://lifesciencesbc.ca/members/abbvie-announces-u-s-fda-approval-of-epkinly-epcoritamab-bysp-in-combination-with-rituximab-and-lenalidomide-for-relapsed-or-refractory-follicular-lymphoma/ 2025-11-18T23:15:50+00:00 https://lifesciencesbc.ca/members/bd-onclarity-hpv-assay-for-bd-cor-and-bd-viper-lt-systems-receive-who-prequalification/ 2025-11-18T23:28:08+00:00 https://lifesciencesbc.ca/members/new-therapeutic-approach-to-facilitate-healing-of-bed-sores/ 2025-11-18T23:53:45+00:00 https://lifesciencesbc.ca/members/inmed-announces-successful-completion-of-pharmacokinetic-studies-in-large-animal-model-for-its-alzheimers-disease-candidate-inm-901/ 2025-11-19T00:04:45+00:00 https://lifesciencesbc.ca/members/new-app-helps-people-with-type-1-diabetes-reachout-to-peers-for-support/ 2025-11-19T00:13:10+00:00 https://lifesciencesbc.ca/members/nervgen-pharma-announces-us10-million-non-brokered-private-placement-to-support-anticipated-nasdaq-listing-and-advance-nvg-291-development/ 2025-11-19T00:23:34+00:00 https://lifesciencesbc.ca/members/new-brunswick-establishes-comprehensive-province-wide-biomarker-testing-program-for-multiple-sclerosis-patients/ 2025-11-19T00:36:09+00:00 https://lifesciencesbc.ca/members/ai-at-the-heart-of-new-sfu-gel-free-ecg-system-for-faster-diagnoses/ 2025-11-19T00:43:13+00:00 https://lifesciencesbc.ca/members/14-5-million-will-move-research-in-sarcomas-bladder-cancer-and-high-risk-brain-cancer-beyond-one-size-fits-all-cancer-care-2/ 2025-11-19T00:49:17+00:00 https://lifesciencesbc.ca/members/nervgen-pharma-announces-closing-of-us10-million-non-brokered-private-placement-to-support-anticipated-nasdaq-listing-and-advance-nvg-291-development/ 2025-11-19T22:31:45+00:00 https://lifesciencesbc.ca/members/arc-presents-positive-ipcoat-glad-01-clinical-safety-data-and-nonclinical-data-at-aagl-2025/ 2025-11-19T23:17:40+00:00 https://lifesciencesbc.ca/members/zymeworks-announces-strategic-initiative-to-optimize-value-of-licensed-products-by-building-a-diversified-portfolio-of-revenue-generating-assets/ 2025-11-20T21:35:57+00:00 https://lifesciencesbc.ca/members/pathway-to-cures-invests-in-seragene-therapeutics/ 2025-11-21T18:11:21+00:00 https://lifesciencesbc.ca/members/bd-nafc-and-medshare-expand-health-access-bring-critical-ultrasound-technology-to-free-and-charitable-clinics-in-30-states/ 2025-11-21T19:09:19+00:00 https://lifesciencesbc.ca/members/castl-launches-bioworks-accelerate-program-to-strengthen-canadas-biomanufacturing-workforce/ 2025-11-21T19:26:55+00:00 https://lifesciencesbc.ca/members/getinge-introduces-new-version-of-solsus-66-to-meet-cssd-efficiency-needs/ 2025-11-21T19:39:37+00:00 https://lifesciencesbc.ca/members/nervgen-pharma-announces-expanded-connect-sci-study-data-demonstrating-unprecedented-durable-improvement-in-function-independence-and-quality-of-life-in-chronic-spinal-cord-injury/ 2025-11-24T19:50:53+00:00 https://lifesciencesbc.ca/members/bd-surgiphor-surgical-wound-irrigation-system-expands-to-europe-to-help-hospitals-improve-patient-safety/ 2025-11-24T19:59:43+00:00 https://lifesciencesbc.ca/members/merck-canada-and-the-pan-canadian-pharmaceutical-alliance-pcpa-successfully-complete-negotiations-for-winrevair-sotatercept/ 2025-11-24T20:19:55+00:00 https://lifesciencesbc.ca/members/arc-medical-announces-jocoat-successfully-deployed-in-20th-orthopedic-surgery-patient/ 2025-11-24T22:11:51+00:00 https://lifesciencesbc.ca/members/new-clinical-evidence-on-hologics-ai-powered-mammography-solutions-will-be-unveiled-at-rsna/ 2025-11-25T17:51:56+00:00 https://lifesciencesbc.ca/members/u-s-fda-grants-priority-review-to-sonrotoclax-for-the-treatment-of-relapsed-or-refractory-mantle-cell-lymphoma/ 2025-11-26T18:45:23+00:00 https://lifesciencesbc.ca/members/ubc-body-swap-robot-helps-reveal-how-the-brain-keeps-us-upright/ 2025-11-26T19:14:03+00:00 https://lifesciencesbc.ca/members/cytiva-and-veeda-lifesciences-drive-biopharma-innovation-with-new-host-cell-protein-services-center/ 2025-11-28T22:23:41+00:00 https://lifesciencesbc.ca/members/new-genome-bc-funded-project-aims-to-bring-bc-closer-to-ending-hiv-transmission/ 2025-11-29T00:15:47+00:00 https://lifesciencesbc.ca/members/new-funding-will-boost-alzheimers-and-parkinsons-research-in-bc/ 2025-11-29T00:25:43+00:00 https://lifesciencesbc.ca/members/grad-students-stride-into-health-research-excellence/ 2025-11-29T00:54:44+00:00 https://lifesciencesbc.ca/members/acuitas-therapeutics-and-partners-publish-comparative-study-of-aav-and-mrna-lnp-delivery-with-in-situ-sequencing-for-spatial-genome-editing/ 2025-12-01T21:20:32+00:00 https://lifesciencesbc.ca/members/new-data-to-be-presented-at-the-2025-sabcs-demonstrates-potential-expanded-utility-of-the-breast-cancer-index-test-the-leading-biomarker-in-personalizing-endocrine-therapy-duration/ 2025-12-02T17:51:05+00:00 https://lifesciencesbc.ca/members/ubc-research-project-aims-to-bring-b-c-closer-to-ending-hiv-transmission/ 2025-12-02T18:26:12+00:00 https://lifesciencesbc.ca/members/bd-launches-new-cell-analyzer-configurations-to-bring-cutting-edge-capabilities-to-labs-of-all-sizes/ 2025-12-03T17:56:59+00:00 https://lifesciencesbc.ca/members/biotecanada-welcomes-the-launch-of-canreview/ 2025-12-03T18:16:24+00:00 https://lifesciencesbc.ca/members/high-risk-early-breast-cancer-patients-in-quebec-left-behind-by-recent-inesss-recommendation/ 2025-12-03T22:48:07+00:00 https://lifesciencesbc.ca/members/bd-and-chemoglo-collaborate-to-expand-hazardous-drug-contamination-testing-for-health-care-facilities-and-laboratories/ 2025-12-04T18:16:32+00:00 https://lifesciencesbc.ca/members/gsk-and-the-pan-canadian-pharmaceutical-alliance-pcpa-successfully-finalize-negotiations-for-jemperli-plus-chemotherapy-for-all-adult-patients-with-primary-advanced-or-first-recurrent-endometrial-ca/ 2025-12-04T18:55:48+00:00 https://lifesciencesbc.ca/members/phase-1-study-advances-a9-3408-an-actinium-225-based-radiotherapeutic-building-on-the-progress-of-the-companys-imaging-agent-a9-3202-which-entered-the-clinic-last-year/ 2025-12-04T21:37:48+00:00 https://lifesciencesbc.ca/ecosystem/56041/ 2025-12-08T21:44:52+00:00 https://lifesciencesbc.ca/wp-content/uploads/2025/12/can-review.webp https://lifesciencesbc.ca/members/arc-medical-treats-first-patient-in-jocoat-orthopedic-surgery-glad-04-pivotal-clinical-trial/ 2025-12-08T22:13:47+00:00 https://lifesciencesbc.ca/members/brukinsa-delivers-landmark-74-6-year-pfs-in-patients-with-treatment-naive-chronic-lymphocytic-leukemia/ 2025-12-08T22:44:56+00:00 https://lifesciencesbc.ca/members/bd-showcases-innovation-in-connected-medication-management-at-ashp-midyear-clinical-meeting/ 2025-12-09T17:27:58+00:00 https://lifesciencesbc.ca/members/biogen-receives-health-canada-authorization-for-zurzuvae-zuranolone-the-first-and-only-treatment-indicated-for-adults-with-postpartum-depression-in-canada/ 2025-12-09T17:35:54+00:00 https://lifesciencesbc.ca/members/cytiva-and-fida-biosystems-collaborate-to-improve-molecular-insight-for-faster-drug-discovery/ 2025-12-09T17:52:55+00:00 https://lifesciencesbc.ca/members/idorsias-treatment-for-insomnia-disorder-wins-the-inaugural-prix-galien-bridges-award-in-the-best-biotechnology-pharmaceutical-product-category/ 2025-12-09T18:10:21+00:00 https://lifesciencesbc.ca/members/earlier-use-of-carvykti-demonstrated-lasting-treatment-free-remissions-at-2-5-years-in-patients-with-relapsed-or-refractory-multiple-myeloma/ 2025-12-09T18:33:06+00:00 https://lifesciencesbc.ca/members/rybrevant-amivantamab-vmjw-plus-lazcluze-lazertinib-delivers-statistically-significant-and-clinic-ally-meaningful-improvement-in-overall-survival-benefit-for-asian-patients-withegfr-mu/ 2025-12-09T18:39:35+00:00 https://lifesciencesbc.ca/members/unprecedented-results-from-the-phase-3-majestec-3-study-support-tecvayli-plus-darzalex-faspro-as-a-potential-standard-of-care-as-early-as-second-line-for-patients-with-relapsed-refractory/ 2025-12-09T18:47:37+00:00 https://lifesciencesbc.ca/members/saskatchewan-adds-capvaxive-to-publicly-funded-adult-immunization-program/ 2025-12-09T18:57:25+00:00 https://lifesciencesbc.ca/members/terry-fox-funded-researchers-uncover-the-origin-of-an-aggressive-sarcoma-of-adolescents-and-young-adults/ 2025-12-09T21:38:16+00:00 https://lifesciencesbc.ca/members/johnson-johnsons-inlexzo-gemcitabine-intravesical-system-delivers-74-percent-disease-free-survival-at-one-year-in-bcg-unresponsive-high-risk-papillary-only-nmibc/ 2025-12-09T21:39:21+00:00 https://lifesciencesbc.ca/members/mlhealth-360-receives-fda-clearance-for-scaida-brainct-ich-canadas-first-ai-solution-for-intracranial-hemorrhage-triage/ 2025-12-10T21:22:21+00:00 https://lifesciencesbc.ca/members/new-hypertension-publication-underscores-aprocitentans-potential-in-managing-hypertension-patients-with-ckd/ 2025-12-10T21:29:36+00:00 https://lifesciencesbc.ca/members/scemblixreceives-priority-access-in-ontario-under-new-fast-program/ 2025-12-10T22:32:05+00:00 https://lifesciencesbc.ca/members/ubrigene-biosciences-and-circurna-announce-strategic-partnership-to-accelerate-development-and-manufacturing-of-circular-rna-lnp-therapeutics/ 2025-12-10T22:57:16+00:00 https://lifesciencesbc.ca/members/vancouver-coastal-health-research-institute-recognized-as-one-of-canadas-leading-hospital-based-research-institutes/ 2025-12-10T23:05:08+00:00 https://lifesciencesbc.ca/members/memphis-healthcare-builders-team-announced-for-regional-one-healths-new-hospital-project/ 2025-12-10T23:09:55+00:00 https://lifesciencesbc.ca/members/well-subsidiary-wellstar-technologies-closes-62m-financing-to-support-its-pre-spinout-growth-strategy/ 2025-12-11T17:41:40+00:00 https://lifesciencesbc.ca/members/admare-bioinnovations-launches-cohort-viii-of-the-executive-institute-to-strengthen-leadership-driving-canadian-life-sciences-company-growth/ 2025-12-12T21:16:00+00:00 https://lifesciencesbc.ca/members/arc-medical-announces-ipcoat-successfully-deployed-in-first-gynecologic-surgery-patient/ 2025-12-15T17:15:57+00:00 https://lifesciencesbc.ca/members/argenx-provides-update-on-uplighted-studies-of-efgartigimod-sc-in-thyroid-eye-disease/ 2025-12-15T17:34:04+00:00 https://lifesciencesbc.ca/members/a-semi-three-dimensional-bioprinted-neurocardiac-system-for-tissue-engineering-of-a-cardiac-autonomic-nervous-system-model-by-hernandez-et-al/ 2025-12-15T17:42:45+00:00 https://lifesciencesbc.ca/members/canadian-hta-assessments-recognize-therapeutic-value-of-qalsody-tofersen-injection-and-its-potential-to-modify-disease-progression-in-individuals-living-with-sod1-als/ 2025-12-15T17:57:17+00:00 https://lifesciencesbc.ca/members/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec/ 2025-12-16T18:28:37+00:00 https://lifesciencesbc.ca/members/hologics-ai-powered-mammography-technology-flagged-a-third-of-breast-cancer-cases-initially-interpreted-as-negative-in-study-of-7500-screening-exams/ 2025-12-16T19:06:27+00:00 https://lifesciencesbc.ca/members/jade-biosciences-announces-45-million-private-placement/ 2025-12-16T19:17:38+00:00 https://lifesciencesbc.ca/members/lexaria-bioscience-corp-announces-3-5-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules/ 2025-12-16T19:40:58+00:00 https://lifesciencesbc.ca/members/wegovy-semaglutide-injection-receives-conditional-marketing-authorization-from-health-canada-as-the-first-and-only-treatment-for-adults-with-non-cirrhotic-mash-a-serious-liver-disease/ 2025-12-16T23:20:44+00:00 https://lifesciencesbc.ca/members/research-evaluation-helps-shape-the-future-of-addiction-treatment-in-bc/ 2025-12-16T23:38:06+00:00 https://lifesciencesbc.ca/members/bd-and-penn-institute-for-immunology-and-immune-health-collaborate-to-advance-immunotherapy-through-flow-cytometry/ 2025-12-19T21:19:49+00:00 https://lifesciencesbc.ca/members/beone-medicines-granted-u-s-fda-fast-track-designation-for-bgb-b2033-as-treatment-for-hepatocellular-carcinoma/ 2025-12-19T21:24:33+00:00 https://lifesciencesbc.ca/members/56258/ 2025-12-19T22:11:56+00:00 https://lifesciencesbc.ca/members/idorsias-daridorexant-in-women-during-menopausal-transition-age-with-insomnia/ 2026-01-05T22:50:32+00:00 https://lifesciencesbc.ca/members/jade-biosciences-outlines-key-2026-objectives-and-strategy-to-advance-pipeline-of-potentially-best-in-class-monoclonal-antibodies-across-multiple-autoimmune-diseases-ahead-of-the-44th-annual-j-p-morg/ 2026-01-05T23:03:31+00:00 https://lifesciencesbc.ca/members/maviret-receives-health-canada-approval-for-the-treatment-of-acute-hepatitis-c-virus/ 2026-01-06T23:00:09+00:00 https://lifesciencesbc.ca/members/bd-marks-milestone-with-first-phasix-hernia-prevention-case-in-greece-and-over-85-enrollment-in-u-s-prevent-trial/ 2026-01-06T23:17:41+00:00 https://lifesciencesbc.ca/members/ziihera-plus-tevimbra-and-chemotherapy-a-potential-new-standard-for-first-line-her2-advanced-gea/ 2026-01-06T23:21:56+00:00 https://lifesciencesbc.ca/members/idorsia-initiates-a-proof-of-concept-trial-with-its-oral-first-in-class-selective-ccr6-antagonist/ 2026-01-06T23:45:45+00:00 https://lifesciencesbc.ca/members/johnson-johnson-unveils-new-data-showing-nipocalimab-is-the-first-and-only-investigational-fcrn-blocker-with-potential-to-reduce-systemic-lupus-erythematosus-sle-activity-in-a-phase-2-study/ 2026-01-06T23:55:23+00:00 https://lifesciencesbc.ca/members/specialized-ai-could-elevate-diabetes-related-blindness-risk-prevention/ 2026-01-07T00:23:45+00:00 https://lifesciencesbc.ca/members/johnson-johnson-submits-application-to-the-european-medicines-agency-for-tecvayli%e2%96%bc-teclistamab-in-combination-with-darzalex-daratumumab-subcutaneous-formulation-for-patients/ 2026-01-07T00:33:12+00:00 https://lifesciencesbc.ca/members/ziihera-zanidatamab-hrii-combinations-achieve-unprecedented-results-in-first-line-her2-locally-advanced-or-metastatic-gea-including-more-than-two-years-median-overall-survival-benefit/ 2026-01-07T00:39:26+00:00 https://lifesciencesbc.ca/members/sustained-therapeutics-reports-positive-phase-2-results-for-its-long-acting-non-opioid-medication-for-chronic-pain/ 2026-01-08T17:24:46+00:00 https://lifesciencesbc.ca/biolinks_longform/david-de-graaf-co-founder-ceo-of-reverb-therapeutics-on-why-vancouver-is-a-great-place-to-build/ 2026-01-08T18:06:38+00:00 https://lifesciencesbc.ca/wp-content/uploads/2026/01/Screenshot-2026-01-08-100451.png https://lifesciencesbc.ca/ecosystem/how-vancouvers-st-pauls-aims-to-become-the-hospital-of-the-future/ 2026-01-08T21:29:40+00:00 https://lifesciencesbc.ca/wp-content/uploads/2026/01/st-pauls.png https://lifesciencesbc.ca/members/acuitas-therapeutics-expands-collaboration-with-rna-technologies-therapeutics-through-strategic-investment/ 2026-01-09T21:02:14+00:00 https://lifesciencesbc.ca/members/amplitude-co-leads-oversubscribed-76-million-series-b-financing-for-mediar-therapeutics/ 2026-01-09T21:15:37+00:00 https://lifesciencesbc.ca/members/stem-cell-engineering-breakthrough-paves-way-for-next-generation-living-drugs/ 2026-01-09T21:52:37+00:00 https://lifesciencesbc.ca/members/100-years-of-healthcare/ 2026-01-09T22:12:39+00:00 https://lifesciencesbc.ca/members/eupraxia-pharmaceuticals-reports-positive-tissue-health-data-from-its-ongoing-resolve-trial-in-eosinophilic-esophagitis-demonstrating-near-complete-improvement-on-biopsy/ 2026-01-09T22:26:06+00:00 https://lifesciencesbc.ca/members/johnson-johnson-celebrates-innovation-in-cancer-research-with-2025-dr-paul-janssen-award/ 2026-01-09T22:54:46+00:00 https://lifesciencesbc.ca/members/lifelabs-named-as-a-1-most-trusted-canadian-brand-for-fourth-consecutive-year/ 2026-01-09T23:06:26+00:00 https://lifesciencesbc.ca/members/abcellera-announces-first-patients-dosed-in-phase-2-portion-of-its-phase-1-2-clinical-trial-of-abcl635-for-the-treatment-of-vasomotor-symptoms-due-to-menopause/ 2026-01-12T18:47:58+00:00 https://lifesciencesbc.ca/members/nature-communications-reports-promising-effect-of-idorsias-lucerastat-on-kidney-function-in-fabry-disease/ 2026-01-12T19:43:39+00:00 https://lifesciencesbc.ca/members/rybrevant-amivantamab-vmjw-longer-term-results-show-promising-and-durable-responses-in-difficult-to-treat-colorectal-cancer/ 2026-01-12T19:52:43+00:00 https://lifesciencesbc.ca/members/health-canada-approves-rybelsus-semaglutide-tablets-to-reduce-the-risk-of-major-adverse-cardiovascular-events-mace-in-adults-with-type-2-diabetes/ 2026-01-12T21:27:06+00:00 https://lifesciencesbc.ca/members/variational-ai-and-rakovina-therapeutics-expand-collaboration-to-accelerate-next-generation-atr-inhibitors/ 2026-01-12T22:39:47+00:00 https://lifesciencesbc.ca/members/aons-latest-glp-1-research-reveals-long-term-employer-cost-savings-and-significant-reductions-in-cancer-risk-for-women/ 2026-01-13T17:58:36+00:00 https://lifesciencesbc.ca/members/argenx-announces-fda-acceptance-of-supplemental-biologics-license-application-with-priority-review-for-vyvgart-in-achr-ab-seronegative-gmg/ 2026-01-13T18:03:54+00:00 https://lifesciencesbc.ca/members/labcorp-expands-mrd-testing-for-breast-lung-and-colon-cancer-recurrence-risk/ 2026-01-13T18:49:31+00:00 https://lifesciencesbc.ca/members/bd-announces-110-million-to-support-u-s-pharmaceutical-supply-chain-for-biologic-drugs/ 2026-01-14T20:06:03+00:00 https://lifesciencesbc.ca/members/admare-bioinnovations-launches-ocythera-a-new-canadian-life-sciences-company-advancing-therapies-for-rare-bone-diseases/ 2026-01-15T18:21:52+00:00 https://lifesciencesbc.ca/members/bd-receives-fda-510k-clearance-for-encor-encompass-breast-biopsy-and-tissue-removal-system/ 2026-01-15T18:51:08+00:00 https://lifesciencesbc.ca/members/xenon-outlines-key-upcoming-milestones-at-the-2026-j-p-morgan-healthcare-conference/ 2026-01-15T21:10:09+00:00 https://lifesciencesbc.ca/members/zymeworks-outlines-strategic-priorities-and-outlook-for-2026/ 2026-01-15T21:14:31+00:00 https://lifesciencesbc.ca/members/bd-to-highlight-advanced-biologics-and-large-volume-delivery-solutions-at-pharmapack-2026/ 2026-01-19T21:30:08+00:00 https://lifesciencesbc.ca/members/new-clinical-data-highlights-caplyta-lumateperone-as-a-promising-option-for-achieving-remission-in-adults-with-major-depressive-disorder/ 2026-01-19T21:56:55+00:00 https://lifesciencesbc.ca/members/aspect-biosystems-and-novo-nordisk-enter-new-phase-of-partnership-to-develop-curative-medicines-for-diabetes/ 2026-01-20T22:49:53+00:00 https://lifesciencesbc.ca/members/eyam-health-and-iidiagnostics-launch-pioneering-uk-canada-collaboration-to-advance-next-generation-vaccine-development/ 2026-01-20T23:20:44+00:00 https://lifesciencesbc.ca/ecosystem/b-c-biotech-boom-feature-globe-mail-article-by-sean-silcoff/ 2026-01-21T01:55:36+00:00 https://lifesciencesbc.ca/wp-content/uploads/2026/01/Screenshot-2026-01-20-174929.png https://lifesciencesbc.ca/members/kardium-announces-publication-of-pulsar-pivotal-trial-results-in-jacc/ 2026-01-21T23:46:52+00:00 https://lifesciencesbc.ca/members/labcorp-named-one-of-the-worlds-most-admired-companies-by-fortune/ 2026-01-21T23:52:29+00:00 https://lifesciencesbc.ca/members/bd-and-ypsomed-expand-partnership-to-address-rapidly-growing-biologics-market/ 2026-01-22T18:00:07+00:00 https://lifesciencesbc.ca/members/lifelabs-opens-new-uptown-new-westminster-patient-service-centre-enhancing-access-to-community-based-diagnostic-care/ 2026-01-22T18:44:08+00:00 https://lifesciencesbc.ca/members/scn-celebrates-25-years-of-transforming-lives-through-regenerative-medicine/ 2026-01-22T19:53:18+00:00 https://lifesciencesbc.ca/members/astrazenecas-tagrisso-and-calquence-among-first-oncology-treatments-granted-accelerated-access-through-ontarios-fast-program/ 2026-01-26T18:27:12+00:00 https://lifesciencesbc.ca/members/bd-helps-scientists-advance-immunology-and-cancer-research-with-ai-powered-insights-and-automation/ 2026-01-26T18:39:48+00:00 https://lifesciencesbc.ca/members/health-canada-authorizes-gazyva-obinutuzumab-for-adults-with-active-lupus-nephritis/ 2026-01-26T19:22:16+00:00 https://lifesciencesbc.ca/members/gilbane-turner-hok-team-has-begun-construction-on-1-7-billion-public-health-laboratory/ 2026-01-27T18:15:55+00:00 https://lifesciencesbc.ca/members/global-expansion-of-idorsias-quviviq-continues-with-ems-partnership-for-latin-america/ 2026-01-28T18:16:44+00:00 https://lifesciencesbc.ca/members/darzalex-faspro-based-quadruplet-regimen-approved-in-the-u-s-for-newly-diagnosed-patients-with-multiple-myeloma-who-are-transplant-ineligible/ 2026-01-28T18:39:00+00:00 https://lifesciencesbc.ca/members/labcorp-collaborates-with-roche-to-bring-fully-automated-mass-spectrometry-to-u-s-clinical-labs/ 2026-01-28T18:40:14+00:00 https://lifesciencesbc.ca/members/platform-co-founded-by-hli-researcher-uses-ai-to-connect-patients-with-clinical-trials/ 2026-01-28T19:35:33+00:00 https://lifesciencesbc.ca/members/scientists-develop-first-gene-editing-treatment-for-skin-conditions/ 2026-01-28T19:53:07+00:00 https://lifesciencesbc.ca/members/bd-and-envetec-demonstrate-closed-loop-recycling-solution-for-laboratory-plastics-in-health-care/ 2026-01-30T18:18:50+00:00 https://lifesciencesbc.ca/members/turner-breaks-ground-on-baptist-health-sunrise-hospital-in-florida/ 2026-02-02T23:05:35+00:00 https://lifesciencesbc.ca/members/idorsia-to-present-long-term-lucerastat-data-and-kidney-biopsy-results-at-worldsymposium/ 2026-02-02T23:34:08+00:00 https://lifesciencesbc.ca/members/johnson-johnson-receives-chmp-positive-opinion-for-akeega-niraparib-and-abiraterone-acetate-dual-action-tablet-for-the-treatment-of-patients-with-metastatic-hormone-sensitive-prostate-cancer/ 2026-02-02T23:47:39+00:00 https://lifesciencesbc.ca/members/me-therapeutics-scientific-and-corporate-update/ 2026-02-03T00:18:27+00:00 https://lifesciencesbc.ca/members/real-world-head-to-head-analysis-shows-51-reduction-in-risk-of-death-for-patients-with-metastatic-castration-sensitive-prostate-cancer-treated-with-erleada-apalutamide-versus-darolutamide-with/ 2026-02-03T00:29:09+00:00 https://lifesciencesbc.ca/members/npk-molecular-you-launch-collaboration-in-precision-healthcare-and-gut-health/ 2026-02-03T00:42:34+00:00 https://lifesciencesbc.ca/members/sino-biological-expands-research-reagent-portfolio-to-support-global-nipah-virus-vaccine-and-diagnostic-development/ 2026-02-03T01:12:59+00:00 https://lifesciencesbc.ca/members/canadian-surgical-innovation-cuts-ovarian-cancer-risk-by-nearly-80-per-cent/ 2026-02-03T02:32:22+00:00 https://lifesciencesbc.ca/members/glowing-bacterial-sensors-detect-gut-illness-in-mice-before-symptoms-emerge/ 2026-02-03T02:42:31+00:00 https://lifesciencesbc.ca/members/balloon-like-particles-help-reveal-hidden-sugar-signals-in-the-immune-system/ 2026-02-03T20:43:35+00:00 https://lifesciencesbc.ca/members/quebec-first-province-to-publicly-reimburse-jemperli-dostarlimab-for-injection-plus-chemotherapy-via-ramq-for-the-treatment-of-all-adult-patients-with-primary-advanced-or-first-recurrent-endometrial/ 2026-02-03T20:49:17+00:00 https://lifesciencesbc.ca/members/phyton-biotech-successfully-completes-corallopyronin-a-technology-transfer/ 2026-02-04T07:32:42+00:00 https://lifesciencesbc.ca/members/hologic-receives-fda-approval-for-aptima-hpv-assay-primary-screening-option-expanding-cervical-health-portfolio/ 2026-02-04T21:27:35+00:00 https://lifesciencesbc.ca/members/labcorp-announces-multi-year-partnership-with-somos-ipa-to-expand-access-to-high-quality-affordable-laboratory-services-for-patients-across-new-york-state/ 2026-02-09T22:04:33+00:00 https://lifesciencesbc.ca/members/lexaria-announces-positive-final-results-from-human-pilot-study-5/ 2026-02-09T22:09:05+00:00 https://lifesciencesbc.ca/members/merck-announces-health-canada-approval-of-enflonsia-for-the-prevention-of-rsv-in-newborns-and-infants/ 2026-02-09T22:15:22+00:00 https://lifesciencesbc.ca/members/kisqali-receives-positive-draft-recommendation-from-canadas-drug-agency-for-all-eligible-early-breast-cancer-patients-at-high-risk-of-recurrence/ 2026-02-09T22:24:18+00:00 https://lifesciencesbc.ca/members/clear-route-to-registration-positions-lucerastat-as-the-potential-first-oral-therapy-for-all-patients-with-fabry-disease/ 2026-02-10T18:07:25+00:00 https://lifesciencesbc.ca/members/using-ai-to-enhance-prevention-of-diabetes-related-blindness/ 2026-02-10T19:57:22+00:00 https://lifesciencesbc.ca/members/labcorp-launches-first-fda-cleared-blood-test-for-alzheimers-disease-assessment-in-primary-care/ 2026-02-11T23:31:44+00:00 https://lifesciencesbc.ca/members/discovery-of-unique-brain-tumour-subtypes-offers-hope-for-targeted-glioma-therapies/ 2026-02-12T00:08:32+00:00 https://lifesciencesbc.ca/members/successful-delivery-of-a-seasonal-influenza-vaccine-in-development-for-aramis-biotechnologies/ 2026-02-12T07:05:06+00:00 https://lifesciencesbc.ca/members/ngbi-podcast-william-annett-of-sustained-therapeutics/ 2026-02-12T21:52:29+00:00 https://lifesciencesbc.ca/members/arbutus-medical-raises-c9-3m-to-accelerate-growth-of-surgical-workflow-solutions-outside-the-or/ 2026-02-17T17:36:48+00:00 https://lifesciencesbc.ca/members/powering-the-next-generation-of-nuclear-medicine-trailblazers/ 2026-02-17T17:50:36+00:00 https://lifesciencesbc.ca/members/fda-approves-rybrevant-faspro-amivantamab-and-hyaluronidase-lpuj-as-the-only-egfr-targeted-therapy-that-can-be-administered-once-a-month/ 2026-02-17T18:37:41+00:00 https://lifesciencesbc.ca/members/rybrevant-faspro-amivantamab-and-hyaluronidase-lpuj-receives-u-s-fda-breakthrough-therapy-designation-for-patients-with-advanced-head-and-neck-cancer/ 2026-02-18T21:40:10+00:00 https://lifesciencesbc.ca/members/health-canada-approves-keytruda-sc-a-subcutaneous-formulation-of-pembrolizumab-across-multiple-cancer-indications/ 2026-02-18T21:48:11+00:00 https://lifesciencesbc.ca/members/cellares-selects-the-netherlands-for-european-headquarters-and-smart-factory/ 2026-02-18T21:55:10+00:00 https://lifesciencesbc.ca/members/ubc-led-team-receives-horizon-europe-funding-to-improve-community-based-care-in-uganda-and-kenya/ 2026-02-18T22:27:02+00:00 https://lifesciencesbc.ca/members/bausch-healths-orapharma-celebrates-25-years-of-arestin-minocycline-hcl-microspheres/ 2026-02-19T18:49:20+00:00 https://lifesciencesbc.ca/members/eisai-maintains-commitment-to-people-living-with-early-alzheimers-disease-despite-cda-amc-draft-recommendation-patients-deserve-access-to-effective-treatment/ 2026-02-19T20:34:52+00:00 https://lifesciencesbc.ca/members/eupraxia-pharmaceuticals-announces-closing-of-us63-2-million-public-offering-including-full-exercise-of-underwriter-option/ 2026-02-23T20:43:35+00:00 https://lifesciencesbc.ca/members/survey-finds-majority-of-older-canadians-with-chronic-illnesses-unaware-of-increased-shingles-risk/ 2026-02-23T20:54:08+00:00 https://lifesciencesbc.ca/members/subcutaneous-rybrevant%e2%96%bc-amivantamab-approved-by-european-commission-for-every-three-week-and-every-four-week-dosing-for-patients-with-advanced-egfr-mutated-non-small-cell-lung-cancer/ 2026-02-24T02:24:31+00:00 https://lifesciencesbc.ca/members/labcorp-expands-collaboration-with-pathai-to-deploy-fda-cleared-digital-pathology-platform-nationwide/ 2026-02-24T02:31:51+00:00 https://lifesciencesbc.ca/members/harnessing-ai-to-improve-ovarian-cancer/ 2026-02-24T03:19:43+00:00 https://lifesciencesbc.ca/members/corcym-receives-health-canada-approval-for-the-miami-instruments-portfolio/ 2026-02-24T18:45:28+00:00 https://lifesciencesbc.ca/members/itovebi-inavolisib-marks-milestone-as-the-first-breast-cancer-treatment-funded-through-ontarios-new-faster-access-program/ 2026-02-25T03:01:25+00:00 https://lifesciencesbc.ca/members/cytiva-expands-fast-trak-process-development-and-validation-services-facility-in-india/ 2026-02-26T05:48:56+00:00 https://lifesciencesbc.ca/members/bausch-healths-aesthetics-business-solta-medical-announces-the-launch-of-clear-brilliant-md-touch-laser-in-canada-english/ 2026-02-26T05:55:42+00:00 https://lifesciencesbc.ca/members/argenx-announces-positive-topline-results-from-phase-3-adapt-oculus-trial-of-vyvgart-in-ocular-myasthenia-gravis/ 2026-02-26T21:55:48+00:00 https://lifesciencesbc.ca/members/gsk-enters-agreement-to-acquire-35pharma-inc/ 2026-02-27T23:59:41+00:00 https://lifesciencesbc.ca/members/early-study-results-from-johnson-johnson-show-promising-antitumor-activity-with-combination-of-pasritamig-and-docetaxel-in-advanced-prostate-cancer/ 2026-02-28T00:39:32+00:00 https://lifesciencesbc.ca/members/bd-pioneers-new-standard-in-surgical-safety-with-fda-cleared-surgiphor-1000ml-for-wound-irrigation/ 2026-03-02T20:22:31+00:00 https://lifesciencesbc.ca/members/odysseabio-expands-strategic-scientific-communication-support-for-biotech-and-life-sciences-teams/ 2026-03-02T22:26:17+00:00 https://lifesciencesbc.ca/members/terry-fox-research-institute-invests-10m-in-national-cancer-prevention-initiative/ 2026-03-02T23:18:48+00:00 https://lifesciencesbc.ca/members/vchri-phase-1-clinical-trials-research-unit-at-ubc-hospital/ 2026-03-02T23:33:14+00:00 https://lifesciencesbc.ca/members/johnson-johnson-therapy-nipocalimab-granted-u-s-fda-fast-track-designation-in-systemic-lupus-erythematosus-sle/ 2026-03-03T18:58:44+00:00 https://lifesciencesbc.ca/members/19th-annual-scotiabank-feast-of-fortune-gala-raises-over-2-5-million-for-st-pauls-foundation-and-providence-health-care/ 2026-03-03T21:31:11+00:00 https://lifesciencesbc.ca/members/health-research-bc-invests-6-3-million-to-strengthen-seniors-home-and-community-care-across-british-columbia/ 2026-03-03T22:55:47+00:00 https://lifesciencesbc.ca/members/genevant-sciences-and-arbutus-biopharma-announce-2-25-billion-global-settlement-with-moderna/ 2026-03-04T21:18:29+00:00 https://lifesciencesbc.ca/members/the-science-behind-a-healthier-brain/ 2026-03-04T22:42:24+00:00 https://lifesciencesbc.ca/members/medtech-dive-labcorp-scales-digital-pathology-through-expanded-pathai-collaboration/ 2026-03-05T19:29:56+00:00 https://lifesciencesbc.ca/members/argenx-to-present-new-data-at-2026-aan-annual-meeting-that-continue-to-transform-patient-outcomes-in-mg-and-cidp-and-build-upon-strength-of-pipeline/ 2026-03-06T19:04:03+00:00 https://lifesciencesbc.ca/members/johnson-johnson-announces-u-s-fda-approval-of-tecvayli-plus-darzalex-faspro-for-relapsed-refractory-multiple-myeloma-offering-a-potential-new-standard-of-care-as-early-as-second-line/ 2026-03-06T19:58:07+00:00 https://lifesciencesbc.ca/members/xenon-announces-positive-topline-data-from-phase-3-x-tole2-study-of-azetukalner-in-focal-onset-seizures-fos/ 2026-03-09T17:09:50+00:00 https://lifesciencesbc.ca/members/inmed-provides-update-on-pharmaceutical-development-programs-advancing-lead-drug-candidates-towards-ind-and-clinical-trial/ 2026-03-09T18:04:22+00:00 https://lifesciencesbc.ca/members/inmed-provides-update-on-baymedica-operations-and-strengthens-focus-on-pharmaceutical-development-pipeline/ 2026-03-09T18:13:25+00:00 https://lifesciencesbc.ca/members/bd-advances-iliac-artery-treatment-across-the-european-union/ 2026-03-10T17:02:11+00:00 https://lifesciencesbc.ca/members/statement-on-biomedical-countermeasures-initiative/ 2026-03-10T17:10:32+00:00 https://lifesciencesbc.ca/members/idorsia-expands-quviviqs-global-ffotprint-through-new-partnership-with-pharmalink/ 2026-03-10T17:38:39+00:00 https://lifesciencesbc.ca/members/european-commission-approves-akeega-niraparib-and-abiraterone-acetate-dual-action-tablet-for-the-treatment-of-patients-with-brca1-2-mutated-metastatic-hormone-sensitive-prostate-cancer-mhspc/ 2026-03-10T17:49:24+00:00 https://lifesciencesbc.ca/members/tecvayli%e2%96%bc-teclistamab-monotherapy-application-submitted-to-the-ema-for-relapsed-refractory-multiple-myeloma-after-at-least-one-prior-yherapy/ 2026-03-10T17:54:56+00:00 https://lifesciencesbc.ca/members/lonza-completes-its-transformation-to-a-pure-play-cdmo-with-agreement-to-divest-capsules-health-ingredients/ 2026-03-10T20:40:21+00:00 https://lifesciencesbc.ca/members/lonza-and-genetix-biotherapeutics-extend-commercial-manufacturing-agreement-for-zynteglo/ 2026-03-10T20:45:18+00:00 https://lifesciencesbc.ca/members/building-better-ways-to-study-cancer/ 2026-03-10T20:53:57+00:00 https://lifesciencesbc.ca/members/wat-medicals-emeterm-wearable-device-demonstrates-superior-control-of-moderate-to-severe-postoperative-nausea-and-vomiting-in-jama-surgery-published-clinical-trial/ 2026-03-11T20:33:59+00:00 https://lifesciencesbc.ca/members/chum-and-roche-diagnostics-canada-inaugurate-a-new-era-of-clinical-diagnostics/ 2026-03-11T21:59:12+00:00 https://lifesciencesbc.ca/members/bd-and-sinteco-expand-advanced-robotics-offering-to-streamline-pharmacy-operations-and-care-quality/ 2026-03-12T16:30:14+00:00 https://lifesciencesbc.ca/members/vertex-announces-positive-week-36-interim-analysis-results-for-primary-and-all-secondary-endpoints-in-the-rainier-phase-3-trial-of-povetacicept-in-adults-with-iga-nephropathy/ 2026-03-12T17:46:47+00:00 https://lifesciencesbc.ca/biolinks_longform/building-trust-in-immune-based-innovations-access-to-innovation-qa/ 2026-03-12T18:41:54+00:00 https://lifesciencesbc.ca/wp-content/uploads/2026/03/LSBCAccesstoInnovation2026-358.jpg https://lifesciencesbc.ca/members/johnson-johnson-highlights-promising-first-in-human-erda-idrs-formerly-tar-210-results-in-intermediate-risk-non-muscle-invasive-bladder-cancer/ 2026-03-13T19:15:08+00:00 https://lifesciencesbc.ca/members/how-reverb-therapeutics-is-redefining-cytokine-based-immunotherapy/ 2026-03-16T23:41:53+00:00 https://lifesciencesbc.ca/members/eupraxia-pharmaceuticals-reports-six-month-symptom-data-from-the-highest-dose-cohort-in-its-ongoing-phase-1b-2a-resolve-trial-in-eosinophilic-esophagitis/ 2026-03-17T17:29:53+00:00 https://lifesciencesbc.ca/members/ubrigene-enables-fda-ind-clearance-for-gt307-til-therapy/ 2026-03-17T18:14:53+00:00 https://lifesciencesbc.ca/members/the-ubc-scientist-who-built-canadas-largest-biotech-company/ 2026-03-17T18:27:08+00:00 https://lifesciencesbc.ca/members/acuitas-therapeutics-lipid-nanoparticle-technology-supports-positive-phase-i-data-published-by-astrazeneca/ 2026-03-18T18:44:42+00:00 https://lifesciencesbc.ca/members/bc-researchers-receive-8-million-in-federal-funding-to-fast-track-genomic-solutions/ 2026-03-18T20:48:32+00:00 https://lifesciencesbc.ca/members/integrated-nanotherapeutics-secures-genome-canada-gapp-funding-to-advance-multi-cargo-mrna-lnp-therapy-for-type-1-diabetes-toward-the-clinic/ 2026-03-18T21:10:26+00:00 https://lifesciencesbc.ca/members/fda-approval-of-icotyde-icotrokinra-ushers-in-new-era-for-first-line-systemic-treatment-of-plaque-psoriasis-with-a-targeted-oral-peptide/ 2026-03-18T21:19:10+00:00 https://lifesciencesbc.ca/members/mintz-advises-sixth-street-in-1-3-billion-financing-supporting-paratek-radius-combination/ 2026-03-18T21:38:22+00:00 https://lifesciencesbc.ca/members/the-video-game-the-body-plays-without-knowing-it/ 2026-03-18T22:06:53+00:00 https://lifesciencesbc.ca/members/ubc-researchers-advance-next-generation-sports-monitoring-through-samsung-collaboration/ 2026-03-18T22:39:46+00:00 https://lifesciencesbc.ca/members/well-health-subsidiary-wellstar-expands-national-billing-platform-with-two-strategic-acquisitions-now-serving-six-provinces/ 2026-03-18T22:52:31+00:00 https://lifesciencesbc.ca/members/esense-launches-north-american-pilot-expanding-access-to-evidence-based-care-for-womens-sexual-health/ 2026-03-20T19:19:57+00:00 https://lifesciencesbc.ca/members/cytiva-and-yoshindo-advance-domestic-biosimilar-manufacturing-in-japan-through-flexfactory-collaboration/ 2026-03-23T20:07:04+00:00 https://lifesciencesbc.ca/members/inmed-pharmaceuticals-announces-positive-data-from-human-brain-organoid-neuroinflammation-models-supporting-the-inm-901-alzheimers-disease-program/ 2026-03-23T20:31:09+00:00 https://lifesciencesbc.ca/members/labcorp-completes-acquisition-of-select-assets-of-crouse-healths-laboratory-alliance-of-central-new-yorks-laboratory-business-enters-agreement-to-manage-crouses-inpatient-l/ 2026-03-23T20:44:06+00:00 https://lifesciencesbc.ca/members/health-canada-approves-ozempic-semaglutide-injection-to-reduce-the-risk-of-major-adverse-cardiovascular-events-mace-in-adults-with-type-2-diabetes/ 2026-03-23T21:10:15+00:00 https://lifesciencesbc.ca/members/well-health-supports-ontarios-commitment-to-a-provincewide-primary-care-medical-record-system/ 2026-03-23T21:33:30+00:00 https://lifesciencesbc.ca/members/merck-to-acquire-terns-pharmaceuticals-inc-expanding-its-hematology-pipeline-with-tern-701-a-novel-candidate-for-chronic-myeloid-leukemia-cml/ 2026-03-25T17:25:26+00:00 https://lifesciencesbc.ca/members/walsh-turner-joint-venture-completes-new-1-5-billion-ohio-state-university-hospital/ 2026-03-25T18:07:05+00:00 https://lifesciencesbc.ca/members/getinge-advances-ecls-technology-with-cardiohelp-ii-the-next-evolution-in-extracorporeal-life-support/ 2026-03-25T18:20:29+00:00 https://lifesciencesbc.ca/members/sugar-based-vaccine-against-bacterial-diarrhea-shows-promise-in-phase-1-trial/ 2026-03-25T18:26:09+00:00 https://lifesciencesbc.ca/members/lexarias-oral-glp-1-drug-strategy-validated-by-industry/ 2026-03-25T18:40:40+00:00 https://lifesciencesbc.ca/members/new-public-listings-for-canadians-living-with-pulmonary-arterial-hypertension/ 2026-03-25T18:47:17+00:00 https://lifesciencesbc.ca/members/combining-ultrasound-and-ai-to-better-customize-cancer-treatment/ 2026-03-25T19:07:03+00:00 https://lifesciencesbc.ca/members/enamine-joins-variational-ai-in-agora-open-science-prmt6-discovery-effort/ 2026-03-25T19:13:53+00:00 https://lifesciencesbc.ca/members/response-biomedical-corp-announces-strategic-collaboration-with-sugentech-inc-to-expand-in-high-growth-global-markets/ 2026-03-27T21:07:16+00:00 https://lifesciencesbc.ca/members/idorsias-daridorexant-delivers-outstanding-results-in-a-phase-2-study-in-children-with-insomnia-disorder/ 2026-03-31T19:59:33+00:00 https://lifesciencesbc.ca/members/bd-launches-ai-enabled-medication-dispensing-system-to-the-european-market/ 2026-04-01T18:48:00+00:00 https://lifesciencesbc.ca/members/icotyde-icotrokinra-one-year-results-confirm-lasting-skin-clearance-and-favorable-safety-profile-in-once-daily-pill-for-plaque-psoriasis/ 2026-04-01T21:27:54+00:00 https://lifesciencesbc.ca/members/inlexzo-gemcitabine-intravesical-system-assigned-permanent-billing-code-supporting-access-for-patients-with-certain-bladder-cancers/ 2026-04-01T21:33:25+00:00 https://lifesciencesbc.ca/members/lexaria-to-begin-new-human-clinical-study-in-glp-1/ 2026-04-01T21:44:49+00:00 https://lifesciencesbc.ca/members/nanovations-ligand-free-lclnp-achieves-complete-b-cell-depletion-in-nhp-at-0-1-mg-kg/ 2026-04-01T22:13:00+00:00 https://lifesciencesbc.ca/members/ubrigene-and-cellinfinity-bio-announce-strategic-partnership-to-advance-in-vivo-car-t-therapies/ 2026-04-01T22:57:04+00:00 https://lifesciencesbc.ca/members/vertex-announces-us-fda-approval-for-label-extensions-of-alyftrek-and-trikafta-expanding-availability-of-these-medicines-to-95-of-all-people-with-cf-in-the-united-states/ 2026-04-01T23:12:22+00:00 https://lifesciencesbc.ca/members/zymeworks-receives-u-s-fda-fast-track-designation-for-zw191-an-fr%ce%b1-targeting-antibody-drug-conjugate/ 2026-04-01T23:20:29+00:00 https://lifesciencesbc.ca/members/aspect-biosystems-announces-280-million-partnership-with-government-of-canada-to-advance-development-of-bioengineered-cellular-medicines/ 2026-04-02T18:23:58+00:00 https://lifesciencesbc.ca/members/federal-government-invests-48-million-in-providence-health-cares-clinical-support-research-centre/ 2026-04-02T20:41:12+00:00 https://lifesciencesbc.ca/members/when-every-beat-matters-bd-helps-clinicians-eliminate-blind-spots-with-continuous-noninvasive-blood-pressure-insight/ 2026-04-07T21:48:01+00:00 https://lifesciencesbc.ca/members/lexaria-applauds-eli-lillys-foundayo-drug-approval/ 2026-04-07T22:49:22+00:00 https://lifesciencesbc.ca/members/nervgen-pharma-announces-successful-end-of-phase-2-meeting-and-fda-alignment-on-restore-a-phase-3-registrational-study-of-nvg-291-for-chronic-tetraplegia/ 2026-04-07T23:07:37+00:00 https://lifesciencesbc.ca/members/a-national-vote-of-confidence-48-million-federal-investment-in-the-jim-pattison-medical-campus-home-of-the-new-st-pauls-hospital/ 2026-04-07T23:39:50+00:00 https://lifesciencesbc.ca/ecosystem/57965/ 2026-04-08T18:55:46+00:00 https://lifesciencesbc.ca/wp-content/uploads/2026/03/Picture1.png https://lifesciencesbc.ca/members/bd-delivers-next-generation-tips-innovation-to-advance-portal-hypertension-care-across-the-european-union/ 2026-04-09T06:18:31+00:00 https://lifesciencesbc.ca/members/variational-ai-releases-enki-4-major-update-to-foundation-model-for-small-molecule-drug-discovery/ 2026-04-09T06:23:58+00:00 https://lifesciencesbc.ca/members/well-health-partners-with-alivecor-to-bring-ai-powered-cardiac-monitoring-and-cardiologist-oversight-to-canadians/ 2026-04-09T07:18:33+00:00 https://lifesciencesbc.ca/members/sino-biological-propure-endotoxin-free-proteins-the-invisible-guardian-of-biopharmaceuticals/ 2026-04-09T07:29:29+00:00 https://lifesciencesbc.ca/members/a-new-milestone-in-robotic-cardiac-surgery-first-use-of-a-purpose-built-robotic-delivery-system-for-surgical-valve-implantation/ 2026-04-09T22:45:03+00:00 https://lifesciencesbc.ca/wp-content/uploads/2021/06/corcym.jpg https://lifesciencesbc.ca/members/saphnelo-subcutaneous-approved-in-canada-for-the-treatment-of-systemic-lupus-erythematosus/ 2026-04-13T18:17:49+00:00 https://lifesciencesbc.ca/members/johnson-johnson-showcases-new-clinical-data-for-tecnis-puresee-iol-at-ascrs-2026-demonstrating-excellent-contrast-sensitivity-and-extended-range-of-vision/ 2026-04-13T22:24:51+00:00 https://lifesciencesbc.ca/members/johnson-johnson-advances-pulsed-field-ablation-portfolio-with-the-launch-of-varipulse-pro-in-europe/ 2026-04-13T22:29:27+00:00 https://lifesciencesbc.ca/members/childrens-hospital-of-philadelphia-and-labcorp-announce-a-collaboration-to-accelerate-access-to-advanced-pediatric-diagnostics-nationwide/ 2026-04-13T22:37:36+00:00 https://lifesciencesbc.ca/members/avantor-enhances-u-s-biomanufacturing-infrastructure-with-expanded-stability-and-microbial-testing-facility/ 2026-04-13T23:42:06+00:00